Citadel Advisors »

Phathom Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $269k 29k 9.13
2023-09-30 $3.0M 292k 10.37
2023-06-30 $877k 61k 14.32
2023-03-31 $1.7M 234k 7.14
2022-12-31 $221k 20k 11.22
2022-06-30 $2.0M 121k 16.67
2022-03-31 $768k 56k 13.62
2021-12-31 $226k 12k 19.71
2021-09-30 $1.1M 36k 32.07
2021-06-30 $2.7M 80k 33.88
2021-03-31 $320k 8.5k 37.45
2020-12-31 $402k 12k 33.25
2020-09-30 $243k 6.7k 36.13
2020-03-31 $308k 12k 25.78